XML 15 R5.htm IDEA: XBRL DOCUMENT v3.26.3
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance at Dec. 31, 2024 $ 565 $ 108,261,264 $ (106,074,505) $ (594,517) $ 1,592,807
Balance, shares at Dec. 31, 2024 56,501        
Stock based compensation 193,848 193,848
Foreign exchange translation loss (3,487) (3,487)
Net loss (2,184,966) (2,184,966)
Exercise of Series A and B Warrants for common shares, net of offering costs $ 385 74,659 75,044
Exercise of Series A and B Warrants for common shares, net of offering costs, shares 38,528        
Issuance of Common Stock and Series A and B and prefunded warrants for cash, net of offering costs $ 1,024 4,243,443 4,244,467
Issuance of Common Stock and Series A and B and prefunded warrants for cash, net of offering costs, shares 102,444        
Issuance of common shares for vested RSAs $ 12 (12)
Issuance of common shares for vested RSAs, shares 1,215        
Issuance of round up shares $ 73 (73)
Issuance of round up shares, shares 7,283        
Balance at Mar. 31, 2025 $ 2,059 112,773,129 (108,259,471) (598,004) 3,917,713
Balance, shares at Mar. 31, 2025 205,971        
Balance at Dec. 31, 2024 $ 565 108,261,264 (106,074,505) (594,517) 1,592,807
Balance, shares at Dec. 31, 2024 56,501        
Foreign exchange translation loss         13,572
Net loss         $ (6,577,816)
Issuance of common shares for vested RSAs, shares         560
Balance at Sep. 30, 2025 $ 5,183 116,684,259 (112,652,321) (580,945) $ 3,456,176
Balance, shares at Sep. 30, 2025 518,296        
Balance at Mar. 31, 2025 $ 2,059 112,773,129 (108,259,471) (598,004) 3,917,713
Balance, shares at Mar. 31, 2025 205,971        
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs $ 462 555,042 555,504
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares 46,197        
Stock based compensation 206,260 206,260
Foreign exchange translation loss 24,473 24,473
Net loss (2,519,181) (2,519,181)
Balance at Jun. 30, 2025 $ 2,521 113,534,431 (110,778,652) (573,531) 2,184,769
Balance, shares at Jun. 30, 2025 252,168        
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs $ 641 1,080,654 1,081,295
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares 64,045        
Stock based compensation 186,981 186,981
Foreign exchange translation loss (7,414) (7,414)
Net loss (1,873,669) (1,873,669)
Exercise of Series A and B Warrants for common shares, net of offering costs $ 2,021 1,882,193 1,884,214
Exercise of Series A and B Warrants for common shares, net of offering costs, shares 202,083        
Deemed dividend on inducement of warrants
Balance at Sep. 30, 2025 $ 5,183 116,684,259 (112,652,321) (580,945) 3,456,176
Balance, shares at Sep. 30, 2025 518,296        
Balance at Dec. 31, 2025 $ 10,615 119,593,456 (114,846,492) (580,038) 4,177,541
Balance, shares at Dec. 31, 2025 1,061,533        
Issuance of Common Stock and warrants in Private Placement, net of offering costs $ 3,288 1,140,739 1,144,027
Issuance of common stock and warrants in Private Placement, net of offering costs, shares 328,802        
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs $ 4,972 1,286,066 1,291,038
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares 497,200        
Stock based compensation 88,673 88,673
Foreign exchange translation loss (7,018) (7,018)
Net loss (1,633,473) (1,633,473)
Balance at Mar. 31, 2026 $ 18,875 122,108,934 (116,479,965) (587,056) 5,060,788
Balance, shares at Mar. 31, 2026 1,887,535        
Balance at Dec. 31, 2025 $ 10,615 119,593,456 (114,846,492) (580,038) 4,177,541
Balance, shares at Dec. 31, 2025 1,061,533        
Foreign exchange translation loss         (19,245)
Net loss         $ (7,210,560)
Issuance of common shares for vested RSAs, shares         8,497
Balance at Sep. 30, 2026 $ 44,758 128,338,745 (122,057,052) (599,283) $ 5,727,168
Balance, shares at Sep. 30, 2026 4,475,884        
Balance at Mar. 31, 2026 $ 18,875 122,108,934 (116,479,965) (587,056) 5,060,788
Balance, shares at Mar. 31, 2026 1,887,535        
Issuance of Common Stock and warrants in Private Placement, net of offering costs $ 980 4,407,758 4,408,738
Issuance of common stock and warrants in Private Placement, net of offering costs, shares 98,000        
Stock based compensation 125,114 125,114
Foreign exchange translation loss (7,625) (7,625)
Net loss (3,027,733) (3,027,733)
Exercise of Series A and B Warrants for common shares, net of offering costs $ 19,503 1,503,739 1,523,242
Exercise of Series A and B Warrants for common shares, net of offering costs, shares 1,950,349        
Balance at Jun. 30, 2026 $ 39,358 128,145,545 (119,507,698) (594,681) 8,082,524
Balance, shares at Jun. 30, 2026 3,935,884        
Stock based compensation 198,546 198,546
Foreign exchange translation loss (4,602) (4,602)
Net loss (2,549,354) (2,549,354)
Exercise of Series A and B Warrants for common shares, net of offering costs $ 5,400 (5,346) 54
Exercise of Series A and B Warrants for common shares, net of offering costs, shares 540,000        
Balance at Sep. 30, 2026 $ 44,758 $ 128,338,745 $ (122,057,052) $ (599,283) $ 5,727,168
Balance, shares at Sep. 30, 2026 4,475,884